CIBMTR

CIBMTR Mission

To lead transformative and collaborative research to improve outcomes in cellular therapy

About CIBMTR

Main Content

News & Events

Quickly access the latest information from CIBMTR.

Please wait while we gather your results.

New Scientific Director

Najla El Jurdi, MD, to Serve as Scientific Director of Graft-versus-Host D...

2024 US Summary Slides

View slides on data submitted to CIBMTR by centers in the US related to pr...

CIBMTR Reaches PRO Protocol Milestone

5,000+ patient-reported outcomes (PRO) surveys have now been collected fro...

In Transplantation and Cellular Therapy Journal: Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR

Review contemporary guidelines for allogeneic hematopoietic cell donor sel...

Scientific Director, Immunobiology Working Committee

CIBMTR is seeking a part time Scientific Director to co-lead our Immunobio...

Become a Corporate Member

This program provides corporations access to the most current and comprehensive data on blood and bone marrow transplantation and an opportunity to participate in CIBMTR annual meetings. The annual memberships provide support for CIBMTR research, which has helped to make tremendous advances in the outcomes of transplantation.

Corporate Membership Options

Work With Us

CIBMTR is dedicated to improving survival, treatment, and quality of life for patients. With more than 1,900 publications, CIBMTR conducts practice-changing research that helps patients and physicians.

Our Data Photo

Our Data

CIBMTR's Outcomes Database contains cellular therapy information for recipients and their donors. CIBMTR collaborates with centers from around the world to collect clinical information from allogeneic transplants, autologous transplants, and other cellular therapies performed worldwide, including nearly all allogeneic transplants and approximately 80% of autologous transplants performed in the US.

View Recipient & Donor Data

Our Studies Photo

Our Studies

CIBMTR is at the forefront of both observational and prospective research in hematopoietic cell transplantation (HCT) and other cellular therapies. We provide opportunities for involvement, resources and data management, and increased visibility for cellular therapy advancements. Anyone committed to furthering the field of cellular therapy can find meaningful ways to become involved and ample support for achieving their goals.

View All Studies

Resources For Data Managers

Center administrators and data managers play a critical role in advancing cellular therapy through complete, accurate, and timely data submission to CIBMTR. These efforts are key in supporting research that has led to increased survival and an enriched quality of life for thousands of patients.

Data Collection Forms

In order to ensure the most relevant data are collected, CIBMTR, in collaboration with the worldwide cellular therapy community, has developed a standard set of data elements to be collected for all transplant and other cellular therapy recipients.

Resources for Data Managers Photo

Manuals & Guides

These reference manuals and guides help data managers learn how to submit data efficiently and smoothly to CIBMTR.

Center Membership

CIBMTR membership offers many advantages to centers, most notably the opportunity to join a large network of physicians and clinical research professionals around the world who share the goal of advancing the science of cellular therapies.

Support & Resources

CIBMTR provides member centers with online tools and resources to communicate with us and securely exchange data.

CIBMTR's Impact

CIBMTR provides a unique resource of information and expertise to the medical and scientific community. Now with data from more than 700,000 patients, more than 1,900 publications, and more than 185 ongoing studies and clinical trials, CIBMTR is at the forefront of research to increase access to cellular therapies and to improve outcomes.

Our Impact